NVS
Novartis AGHealthcare$154.03
◆ Neutral
Mkt Cap: $297.32B|Float: 1.82B|SI: 0.4%|DTC: 2.6
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
2012.0%
52W Range
$95-$165
ATR(14)
$2.68
Exp. Move
±4.1%
P/C Ratio
2.23
Earnings
Apr 28
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
High Put/Call
NVS Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $2.0M
- Max Pain
- $155.00
- Expected Move
- ±4.1%
- Put/Call OI
- 2.23
- Net Premium
- $62.8M
- Spot Price
- $154.03
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$6.25 | ±4.1% | $147.78 | $160.28 |
| 2026-05-15 | 43 | ±$11.30 | ±7.3% | $142.73 | $165.33 |
| 2026-06-18 | 77 | ±$14.75 | ±9.6% | $139.28 | $168.78 |
| 2026-07-17 | 106 | ±$17.05 | ±11.1% | $136.98 | $171.08 |
| 2026-10-16 | 197 | ±$23.50 | ±15.3% | $130.53 | $177.53 |
| 2026-12-18 | 260 | ±$26.35 | ±17.1% | $127.68 | $180.38 |
Explore NVS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.